Jorge Manchola, a retired Air Force staff sergeant, was diagnosed with stage 4 lung cancer in 2023. The cancer had spread to ...

Dr. Soon-Shiong is hopeful the Saudi Arabian FDA's approval of his cancer therapy drug, Anktiva, will lead to widespread ...

A research team has made a breakthrough in epigenetic drug discovery. The researchers have successfully developed a ...

A new report from the American Cancer Association predicts lung cancer will cause more deaths than any other in 2026.

Ibuprofen is a household name – the go-to remedy for everything from headaches to period pain. But recent research suggests ...

Saudi Arabia leads the way as the first country to grant conditional approval for Anktiva, a groundbreaking treatment for ...

A team led by investigators at the Mass General Brigham Cancer Institute has discovered that a particular marker on tumor ...

Shares of ImmunityBio rose to a three-month high after the company reported positive results from clinical trials of its Anktiva immunotherapy to treat lung cancer patients. The stock closed the ...

A new gene therapy for people who can have a stem cell transplant but do not have a suitable donor has been approved.

Despite a significant 48.8% objective response rate and breakthrough therapy status, this regulatory shift reverses years of ...

The drug is not considered a cure, but results emerging from clinical trials point to the first major advancement in decades ...

The early-stage clinical trial marks the first U.S. testing of Alveltamig, an immunotherapy designed to help the immune ...